548 related articles for article (PubMed ID: 15158621)
1. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Bednarek J; Wysocki H; Sowiński J
Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
[TBL] [Abstract][Full Text] [Related]
2. [The effect of one-month antithyroid therapy on peripheral metabolism of reactive oxygen species in Graves' disease with infiltrative ophthalmopathy].
Bednarek J; Wysocki H; Sowiński J
Przegl Lek; 2004; 61(8):841-4. PubMed ID: 15789912
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
Bednarek J; Wysocki H; Sowiński J
Clin Biochem; 2005 Jan; 38(1):13-8. PubMed ID: 15607311
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress profile in graves' ophthalmopathy in Indian patients.
Kaur A; Pandey S; Kumar S; Mehdi AA; Mishra A
Orbit; 2010 Apr; 29(2):97-101. PubMed ID: 20394549
[TBL] [Abstract][Full Text] [Related]
5. Oxidation products and antioxidant markers in plasma of patients with Graves' disease and toxic multinodular goiter: effect of methimazole treatment.
Bednarek J; Wysocki H; Sowinski J
Free Radic Res; 2004 Jun; 38(6):659-64. PubMed ID: 15346657
[TBL] [Abstract][Full Text] [Related]
6. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
Wakelkamp IM; Prummel MF; Wiersinga WM
Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
8. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
9. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
Akarsu E; Buyukhatipoglu H; Aktaran S; Kurtul N
Clin Endocrinol (Oxf); 2011 Jan; 74(1):118-24. PubMed ID: 21044110
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy?
Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I
Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant enzymes, glutathione and lipid peroxidation in peripheral blood of children affected by coeliac disease.
Stojiljković V; Todorović A; Radlović N; Pejić S; Mladenović M; Kasapović J; Pajović SB
Ann Clin Biochem; 2007 Nov; 44(Pt 6):537-43. PubMed ID: 17961308
[TBL] [Abstract][Full Text] [Related]
12. Blood oxidative stress markers in Gaucher disease patients.
Roversi FM; Galdieri LC; Grego BH; Souza FG; Micheletti C; Martins AM; D'Almeida V
Clin Chim Acta; 2006 Feb; 364(1-2):316-20. PubMed ID: 16125160
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant status and lipid peroxidation in the blood of breast cancer patients of different ages.
Kasapović J; Pejić S; Todorović A; Stojiljković V; Pajović SB
Cell Biochem Funct; 2008 Aug; 26(6):723-30. PubMed ID: 18636415
[TBL] [Abstract][Full Text] [Related]
14. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
15. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
[TBL] [Abstract][Full Text] [Related]
16. Exercise, depletion of antioxidants and antioxidant manipulation.
Balakrishnan SD; Anuradha CV
Cell Biochem Funct; 1998 Dec; 16(4):269-75. PubMed ID: 9857489
[TBL] [Abstract][Full Text] [Related]
17. Influence of therapy on the antioxidant status in patients with melanoma.
Gadjeva V; Dimov A; Georgieva N
J Clin Pharm Ther; 2008 Apr; 33(2):179-85. PubMed ID: 18315784
[TBL] [Abstract][Full Text] [Related]
18. Allergy to drugs: antioxidant enzymic activities, lipid peroxidation and protein oxidative damage in human blood.
Matés JM; Pérez-Gómez C; Olalla L; Segura JM; Blanca M
Cell Biochem Funct; 2000 Jun; 18(2):77-84. PubMed ID: 10814964
[TBL] [Abstract][Full Text] [Related]
19. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids.
Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I
Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760
[TBL] [Abstract][Full Text] [Related]
20. Lack of changes in the concentration of thiobarbituric acid-reactive substances (TBARS) and in the activities of erythrocyte antioxidant enzymes in alcohol-dependent patients after detoxification.
Woźniak B; Musiałkiewicz D; Woźniak A; Drewa G; Drewa T; Drewa S; Mila-Kierzenkowska C; Porzych M; Musiałkiewicz M
Med Sci Monit; 2008 Jan; 14(1):CR32-36. PubMed ID: 18160942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
